Evidence map›Paper›PMID 11081197›Full record

ArticlePituitary1999

Distribution and regulation of proconvertases PC1 and PC2 in human pituitary adenomas.

L Jin, E Kulig, X Qian, B W Scheithauer, W F Young, D H Davis, N G Seidah, M Chretien, R V Lloyd

Abstract read
PubMed Publisher
In one paragraph

Article in Pituitary, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

L JinDepartment of Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA.
E Kulig
X Qian
B W Scheithauer
W F Young
D H Davis
N G Seidah
M Chretien
R V Lloyd
Mayo Clinic · USMontreal Clinical Research Institute · CAMayo Clinic in Arizona · US

Funding

STUDIES OF NORMAL AND NEOPLASTIC HUMAN PITUITARY TISSUER01CA042951 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LLOYD, RICARDO VINCENT · 1986 to 1997
–
NCI NIH HHS CA 42951
6 · The paper itself

Abstract

Pituitary adenomas are members of the family of neuroendocrine cells and tumors which have secretory granules containing chromogranins/secretogranins and other proteins. Pituitary adenomas express the neuroendocrine specific proconvertases PC1 (also known as PC3) and PC2, which are important for the proteolytic processing of chromogranins/secretogranins molecules. We examined the distribution of PC1 and PC2 in primary cultures of 20 pituitary adenomas and analyzed the regulation of the proconvertase mRNAs and proteins by various secretagogues including hypothalamic hormones and phorbol ester to determine the role of PC1 and PC2 in CgA processing in pituitary adenomas. Although PC2 was present in all adenomas, there was a differential distribution of PC1 with PRL adenomas expressing lower levels of PC1 compared to other adenoma types by RT-PCR analysis, in situ hybridization and immunostaining. Treatment of primary cultures of pituitary adenomas with phorbol 12-myristrate 13-acetate (PMA) resulted in an increase in pancreastatin (PST) secretion in most pituitary adenomas and increased PC1 mRNA and protein expression in gonadotroph adenomas, but not in other types of adenomas. Analysis of a human pituitary adenoma cell line, immortalized by recombinant defective adenovirus (HP75), which expressed chromogranin A, FSH, PC1 and PC2 showed that PST was secreted by these immortalized cells. Treatment with TGF beta 1 resulted in an increase in PST secretion and in PC1 mRNA and protein. These results indicate that a) there is a differential distribution of PC1 in human pituitary adenomas with PRL adenomas expressing very little PC1 mRNA and protein and b) that PC1 expression in gonadotropin hormone-producing adenomas is regulated by PMA and TGF beta 1. These findings support the observation that chromogranin A is a substrate for the endoproteinase PC1 in human pituitary adenoma cells.

Indexed as

AdenomaAspartic Acid EndopeptidasesBase SequenceChromogranin AChromograninsDNA PrimersHumansImmunohistochemistryIn Situ HybridizationPancreatic HormonesPituitary HormonesPituitary NeoplasmsProprotein Convertase 2Proprotein ConvertasesReverse Transcriptase Polymerase Chain ReactionRNA, MessengerAspartic Acid EndopeptidasesChromogranin AChromograninsDNA PrimerspancreastatinPancreatic HormonesPituitary HormonesProprotein Convertase 2Proprotein ConvertasesRNA, MessengerRNA, NeoplasmSubtilisins

Identifiers

PMID11081197
OpenAlexW124061506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.